The concept of selectivity in 5-HT receptor research
- PMID: 2164935
- DOI: 10.1016/0922-4106(90)90190-9
The concept of selectivity in 5-HT receptor research
Abstract
Since the demonstration that serotonin (5-hydroxytryptamine, 5-HT) interacts with different (sub)types of membrane receptors, several compounds have been proposed as potent and selective ligands for one of these 5-HT subtypes. Unfortunately, specific and highly selective ligands (selectivity ratios greater than or equal to 1000) for the majority of 5-HT subtypes are still lacking. A few compounds are selective (ratios greater than or equal to 100), but most of the reputed 'selective' tools display affinities for other 5-HT subtypes and/or other (neuro-) transmitter receptors. Mainly due to different interpretations of the concept of selectivity, many of these nonselective compounds are still used to characterize 5-HT receptors. In this paper, we present the affinities (obtained by radioligand binding studies) of the most selective tools known today for each of the 5-HT subtypes and discuss the structure-activity relationships of some interesting series. The potential use of several of these selective ligands as pharmacological tools and therapeutics will be briefly reviewed.
Similar articles
-
2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.J Med Chem. 1999 Jul 29;42(15):2870-80. doi: 10.1021/jm981098j. J Med Chem. 1999. PMID: 10425096
-
Synthesis and pharmacological characterization of a series of geometrically constrained 5-HT(2A/2C) receptor ligands.J Med Chem. 2003 Jul 31;46(16):3526-35. doi: 10.1021/jm030064v. J Med Chem. 2003. PMID: 12877591
-
New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation.J Med Chem. 2005 Aug 25;48(17):5495-503. doi: 10.1021/jm050246k. J Med Chem. 2005. PMID: 16107148
-
5-HT(6) receptor modulators: a patent update. Part 2. Diversity in heterocyclic scaffolds.Expert Opin Ther Pat. 2012 Oct;22(10):1123-68. doi: 10.1517/13543776.2012.722205. Epub 2012 Sep 7. Expert Opin Ther Pat. 2012. PMID: 22957857 Review.
-
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).Pharmacol Rev. 1994 Jun;46(2):157-203. Pharmacol Rev. 1994. PMID: 7938165 Review.
Cited by
-
Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI.J Neurosci. 2002 Nov 1;22(21):9635-42. doi: 10.1523/JNEUROSCI.22-21-09635.2002. J Neurosci. 2002. PMID: 12417689 Free PMC article.
-
Effect of pretreatment with palonosetron on withdrawal movement associated with rocuronium injection.Korean J Anesthesiol. 2014 Jan;66(1):23-7. doi: 10.4097/kjae.2014.66.1.23. Epub 2014 Jan 28. Korean J Anesthesiol. 2014. PMID: 24567809 Free PMC article.
-
5HT drugs in animal models of anxiety.Psychopharmacology (Berl). 1993;112(1):13-20. doi: 10.1007/BF02247358. Psychopharmacology (Berl). 1993. PMID: 7871002 Review.
-
The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin. (Rapid communication).J Neural Transm (Vienna). 1997;104(4-5):561-4. doi: 10.1007/BF01277672. J Neural Transm (Vienna). 1997. PMID: 9295186
-
Performance of compulsive behavior in rats is not a unitary phenomenon - validation of separate functional components in compulsive checking behavior.Eur J Neurosci. 2014 Sep;40(6):2971-9. doi: 10.1111/ejn.12652. Epub 2014 Jun 16. Eur J Neurosci. 2014. PMID: 24935528 Free PMC article.